531210 logo

Colinz Laboratories Stock Price

Symbol: BSE:531210Market Cap: ₹111.9mCategory: Pharmaceuticals & Biotech

531210 Share Price Performance

Community Fair Values

    Recent 531210 News & Updates

    No updates

    Colinz Laboratories Limited Key Details

    ₹65.3m

    Revenue

    ₹20.9m

    Cost of Revenue

    ₹44.4m

    Gross Profit

    ₹39.4m

    Other Expenses

    ₹5.0m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    1.97
    Gross Margin
    67.98%
    Net Profit Margin
    7.61%
    Debt/Equity Ratio
    6.8%

    Colinz Laboratories Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 531210

    Founded
    1986
    Employees
    69
    CEO
    Narayanan Menon
    WebsiteView website
    www.colinz.com

    Colinz Laboratories Limited manufactures, markets, and trades in pharmaceutical formulations in India. The company offers pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, and creams, etc.; and specialized products for gynecology, cardiology, and gastroenterology, etc. Its allopathy products include oncology products, such as imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, doxorubicin, filgrastim, and pegylated liposome doxorubicin, etc.; antiritrovirals, including lopinavir, indinavir, ritonavir, darunavir, zidovudine, lamivudin, and various combination therapy products; and products for other therapeutic areas, such as antibiotics, anti-fungals, anti-malarials, anti-virals, anti-manics, anti-convulsants, anti-migraines, anti-allergics, anthelmintics, anti-emetics, sedatives, cerebral activators, ulcer healing agents, laxatives, probiotics, digestive enzymes, topical steroids, ear/eye drops, hormones, sunscreens, and vitamins, etc., as well as drugs used in protozoal infestations and neuropathy. In addition, the company offers ayurvedic products comprising anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, memory boosters, anti-piles, antacids, liver tonics, ulcer healing agents, digestive agents, uterine tonics, anti-diabetics, and general tonics, as well as drugs to treat oligospermia and erectile dysfunction. Further, it provides nutraceuticals, including spirulina tabs/caps, spirulina with vitamins and minerals, omega 3 fatty acids caps in softgel, codliver oil with vitamin caps in soft gel, amino acids tabs/caps, l-arginine with proantocyanidin granules, and hair growth formulations, etc., as well as collagen, glucosamine, and chondroitin tabs. Colinz Laboratories Limited was incorporated in 1986 and is based in Mumbai, India.

    Indian Market Performance

    • 7 Days: -1.8%
    • 3 Months: 5.5%
    • 1 Year: -6.0%
    • Year to Date: -0.3%
    Over the last 7 days, the market has dropped 1.8%, driven by a decline of 2.7% in the Financials sector. As for last year, the market is also down 6.0%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading